Dr. Allan Brett discusses why we should wait for publication of the complete findings before adjusting patients' antihypertensive drug regimens.
Dear readers,
The SPRINT research study, funded by the National Institutes of Health to determine whether lower blood pressure would reduce risks for heart and kidney diseases, stroke, or age-related declines in memory and thinking, was stopped early due to a clear advantage for the intensively treated group. Dr. Allan Brett, NEJM Journal Watch General Medicine Editor-in-Chief, offers his take on how clinicians should advise their patients. We hope you enjoy this audio feature.
— The NEJM Journal Watch Editors